US20020006415A1 - Chemically active fiber compositions as delivery system for chemotherpeutic agents, epecially for substances useful in dental hygiene - Google Patents
Chemically active fiber compositions as delivery system for chemotherpeutic agents, epecially for substances useful in dental hygiene Download PDFInfo
- Publication number
- US20020006415A1 US20020006415A1 US09/245,625 US24562599A US2002006415A1 US 20020006415 A1 US20020006415 A1 US 20020006415A1 US 24562599 A US24562599 A US 24562599A US 2002006415 A1 US2002006415 A1 US 2002006415A1
- Authority
- US
- United States
- Prior art keywords
- fiber
- imbibed
- fluoride
- chemotherapeutic agent
- grams per
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000835 fiber Substances 0.000 title claims abstract description 112
- 239000000126 substance Substances 0.000 title claims abstract description 36
- 239000000203 mixture Substances 0.000 title claims description 13
- 239000003795 chemical substances by application Substances 0.000 title abstract description 10
- 241000628997 Flos Species 0.000 claims abstract description 65
- 229920000642 polymer Polymers 0.000 claims abstract description 32
- 239000002246 antineoplastic agent Substances 0.000 claims abstract description 27
- 229940127089 cytotoxic agent Drugs 0.000 claims abstract description 26
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims description 58
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- 239000011775 sodium fluoride Substances 0.000 claims description 29
- 235000013024 sodium fluoride Nutrition 0.000 claims description 29
- 229930182555 Penicillin Natural products 0.000 claims description 14
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 12
- 229940049954 penicillin Drugs 0.000 claims description 12
- 229920001778 nylon Polymers 0.000 claims description 8
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 7
- 239000004677 Nylon Substances 0.000 claims description 7
- 229960003260 chlorhexidine Drugs 0.000 claims description 7
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 239000006185 dispersion Substances 0.000 claims description 6
- 229920000728 polyester Polymers 0.000 claims description 6
- 150000001408 amides Chemical class 0.000 claims description 5
- 150000003949 imides Chemical class 0.000 claims description 5
- 229920000570 polyether Polymers 0.000 claims description 5
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 4
- 229960002799 stannous fluoride Drugs 0.000 claims description 3
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 claims description 3
- 150000004673 fluoride salts Chemical class 0.000 claims 2
- 239000003125 aqueous solvent Substances 0.000 claims 1
- 229920002334 Spandex Polymers 0.000 abstract description 35
- 239000004759 spandex Substances 0.000 abstract description 35
- 229940091249 fluoride supplement Drugs 0.000 description 24
- 239000000243 solution Substances 0.000 description 19
- 239000008367 deionised water Substances 0.000 description 10
- 229910021641 deionized water Inorganic materials 0.000 description 10
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 8
- 229920001971 elastomer Polymers 0.000 description 8
- 229910052731 fluorine Inorganic materials 0.000 description 8
- 239000011737 fluorine Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- -1 aliphatic acyl amide Chemical class 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000806 elastomer Substances 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 208000002925 dental caries Diseases 0.000 description 3
- 208000007565 gingivitis Diseases 0.000 description 3
- 229940051866 mouthwash Drugs 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 2
- 206010013911 Dysgeusia Diseases 0.000 description 2
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 2
- 244000043261 Hevea brasiliensis Species 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 229940064004 antiseptic throat preparations Drugs 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 150000002222 fluorine compounds Chemical class 0.000 description 2
- 229960002949 fluorouracil Drugs 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- BWHLPLXXIDYSNW-UHFFFAOYSA-N ketorolac tromethamine Chemical compound OCC(N)(CO)CO.OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 BWHLPLXXIDYSNW-UHFFFAOYSA-N 0.000 description 2
- 230000003641 microbiacidal effect Effects 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- 229920003052 natural elastomer Polymers 0.000 description 2
- 229920001194 natural rubber Polymers 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 150000002960 penicillins Chemical class 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000011287 therapeutic dose Methods 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- QOPBEBWGSGFROG-UHFFFAOYSA-N 2-(1h-indol-2-yl)acetic acid Chemical class C1=CC=C2NC(CC(=O)O)=CC2=C1 QOPBEBWGSGFROG-UHFFFAOYSA-N 0.000 description 1
- 239000004101 4-Hexylresorcinol Substances 0.000 description 1
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 description 1
- WFJIVOKAWHGMBH-UHFFFAOYSA-N 4-hexylbenzene-1,3-diol Chemical compound CCCCCCC1=CC=C(O)C=C1O WFJIVOKAWHGMBH-UHFFFAOYSA-N 0.000 description 1
- 235000019360 4-hexylresorcinol Nutrition 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 239000004343 Calcium peroxide Substances 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920000544 Gore-Tex Polymers 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 241000399716 Homola Species 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920000299 Nylon 12 Polymers 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004105 Penicillin G potassium Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229940112258 acular Drugs 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000398 anti-amebic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000656 anti-yeast Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229940034982 antineoplastic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 238000010420 art technique Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 150000004287 bisbiguanides Chemical class 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 1
- 235000019402 calcium peroxide Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229940047495 celebrex Drugs 0.000 description 1
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 229960005443 chloroxylenol Drugs 0.000 description 1
- 208000019884 chronic gingivitis Diseases 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 229940111134 coxibs Drugs 0.000 description 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 239000003975 dentin desensitizing agent Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000019564 dysgeusia Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
- 229960004884 fluconazole Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- 229960003258 hexylresorcinol Drugs 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 229940089536 indocin Drugs 0.000 description 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 1
- 201000006747 infectious mononucleosis Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229960004384 ketorolac tromethamine Drugs 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 235000019368 penicillin G potassium Nutrition 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical class OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 239000008262 pumice Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229960000414 sodium fluoride Drugs 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- NESLWCLHZZISNB-UHFFFAOYSA-M sodium phenolate Chemical compound [Na+].[O-]C1=CC=CC=C1 NESLWCLHZZISNB-UHFFFAOYSA-M 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
- 229960001082 trimethoprim Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000004636 vulcanized rubber Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
Definitions
- This invention relates to dental hygiene.
- this invention relates an imbibed fiber that can be used as a delivery system for substances useful in dental hygiene.
- Dental floss is a very well known and broadly used article of dental hygiene. There are many benefits attributed to dental flossing, and especially daily dental flossing. Dental flossing removes residual food particles, which cannot be removed by brushing, from in between teeth, and in general maintains the gums in good health. Thus, among other benefits, it decreases the incidence of dental caries, gingivitis, halitosis, and dysgeusia (bad taste). It may also reduce the incidence of plaque formation.
- the invention is a imbibed polymer, preferably an imbibed fiber, comprising:
- Imbibed polymer may be in the form of, for example, a dental tape, a molded object, or a monolith.
- the imbibed fiber may be in the form of, for example, yarn, fabric, or a gauze pad.
- the imbibed dental floss strand preferably comprises an elastomer having:
- the fiber requires a stress of either about 0.03 to 0.40 grams per denier, more preferably about 0.04 to 0.25 grams per denier, and even more preferably about 0.04 to 0.20 grams per denier, in order to develop an elongation of 200%, or about 0.07 to 0.60 grams per denier, more preferably about 0.08 to 0.50 grams per denier, and even more preferably about 0.09 to 0.30 grams per denier, in order to develop an elongation of 300%.
- the preferred denier value for the elastomeric fiber is about 40 to 4,000, preferably about 200 to 2,500, and more preferably about 800 to 2,400.
- Elastomeric fibers other than spandex fibers may be used as long as they fulfil these three important requirements along with the requirements of denier value, texture, smoothness, and the like.
- the fiber should preferably be stable with age.
- the fiber should not lose more than 20% of its original tensile strength in one year, and more preferably it should lose not more than 10% per year.
- Elastomeric dental floss is disclosed in Burch, U.S. Pat. No. 5,433,266 (equivalent to WO 95/24167), incorporated herein by reference.
- the dental floss comprises a fiber having a core of a segmented polymer having soft segments and hard segments.
- the hard segments are selected from a group consisting of urethane, amide, imide, and mixtures thereof. Urethane hard segments are, however, highly preferable.
- the hard and soft segments belong to the same polymer and they are linked chemically by covalent bonds.
- the hard segments give the fibers and filaments strength and integrity.
- the soft segments give the fibers and filaments their elasticity.
- the core of the fiber has preferably a content of hard segment of 5-40% by weight, while the soft segments are preferably selected from the group consisting of polyester, polyether, and mixtures thereof.
- the structure of the core of the fiber is preferably selected from the group consisting of primary monofilament, primary multifilament, primary coalesced monofilament, and combinations thereof.
- the core of the fiber may be uncovered or bare core, core covered with a secondary filament, or a combination thereof.
- the secondary filament may be a secondary monofilament, secondary multifilament, spun filament, or a combination thereof.
- the content in hard segments is preferably in the range of 5-40% by weight of the total polymer, and more preferably in the range of 15-25% by weight of the total polymer.
- the content of the soft segment is preferably in the range of 60-95% by weight of the total polymer, and more preferably in the range of 75-85% by weight of the total polymer.
- Examples of such polymers are polymers having the generic name “spandex”.
- Spandex A review of spandex elastomeric fibers is given by L. Rose in the Reprints, Progress in Applied Chemistry ( London ), Vol. 51, p. 609, 1966, incorporated herein by reference.
- Meredith and Fyfe in Text Inst. Ind., Vol. 2, p. 154, 1964, and Bamford in Text. Inst. Ind., Vol. 55, p. 73, 1965, discuss the structural aspects of spandex, and give suggestions about its elastomeric properties.
- the hard segments of preferably aromatic polyurea are linked occasionally to the soft segments through urethane bonds, and these bonds are analogous to the covalent sulfide bonds of vulcanized rubber.
- the soft segments consist of a polymeric structure with a glass transition temperature well below room temperature.
- the soft segments in the case of spandex, which are preferably polyethers, polyesters, or a combination thereof, have preferably low internal cohesion, and they are analogous to the hydrocarbon chains in the case of natural rubber.
- the soft segments can dissolve other substances, such as those useful in dental hygiene.
- Hytrel® elastomer (DuPont, Wilmington, Del.) may also be useful, but its low content of soft segments limits the amount of substance that may be imbibed in the fiber. Natural rubber may also be useful, but its hydrocarbon-like character limits the type of substances to that can be imbibed to hydrocarbon-like small molecules and its low tensile strength is a problem in dental applications.
- spandex fiber has a variable diameter that depends on stretching. The diameter decreases with stretch and percent decrease in diameter related to the degree of stretch. It returns to original diameter with release of stretch. Thus, it can accommodate and clean spacings of different dimensions between teeth.
- spandex fibers include, but are not limited to: easy and safe to use, i.e., the variable diameter with stretch enables use in variable teeth spacing; because of its good tensile strength, it does not break easily, as compared to rubber dental floss, which is prone to break easily and injure the gums of the user; once wrapped around the index finger for use, the stretch release anchors the spandex fiber with less chance of slipping, when compared to regular floss; and considerably more comfortable to the gums. Its wet smooth surface avoids gum injury. It is hypo-allergenic, and it does not have the tackiness, stickiness and unpleasant odor of rubber. It is inexpensive.
- the core of the fiber may be a primary monofilament.
- the primary monofilament preferably has a round cross-section.
- the cross-section may have any other shape, such as for example square, rectangular, polygonal, irregular, and the like.
- the diameter of the primary monofilament may also be variable.
- the core of the fiber may also be in the form of a primary multifilament.
- Monofilaments may be woven together, twisted, and in general formed in any conventional manner that fibers are manufactured. Further, the monofilaments may be coalesced into one primary coalesced monofilament, somewhat similar to the primary multifilament, with the difference that the monofilaments have been fused together to a desired degree, at least at the contact regions of the monofilaments, to form the unitary primary coalesced monofilament.
- the core may be bare or covered partially or totally with a secondary monofilament or polyfilament. It may also be covered by more than one secondary mono- or multifilament.
- the core may be covered by a secondary spun filament.
- the secondary filaments may be any conventional fibers, elastomeric or non-elastic, such as, for example, nylon, acrylic, acetate, cotton, wool, polyester, Lycra® spandex, other natural or synthetic fibers, and the like.
- the fiber comprises at least a therapeutically effective amount of a chemotherapeutic agent, especially a substance useful in dental hygiene.
- a chemotherapeutic agent especially a substance useful in dental hygiene.
- the agent preferably has sufficient solubility in water so that it can be imbibed into the fiber and extracted from the fiber when the fiber is placed in the user's mouth. More than one agent may be included, if desired.
- terapéuticaally effective amount is meant the amount necessary to achieve a desired therapeutic effect. As is well known to those skilled in the art this will depend on the agent used and the therapeutic effect desired.
- Chemotherapeutic agents especially substances useful in dental hygiene, can be imbibed into the fiber.
- Chemotherapeutic agents include, but are not limited to, chemical agents used as bacteriacidals, antiseptics, anti-inflammatories, anti-fungals, and agents for the treatment of cancer.
- anti-bacterials such as sulfonamides, penicillins, trimethoprim, and, zinc salts, such as zinc acetate and zinc chloride
- anti-amoebics such as zinc acetate and zinc chloride
- anti-yeasts such as anti-fungals, such as nystatin and fluconazole
- antiseptics for example, fluorides, such as sodium fluoride and stannous fluoride, chlorhexidine, triclosan, thymol, chloroxylenol, hexachlorophene, phenol derivatives, such as sodium phenolate and 4-hexylresorcinol
- anti-inflammatory agents for example, salicylates, such as aspirin, phenylacetic acids, such as ibuprofen, indoleacetic acids, such as indocin, ketorolac tromethamine (Acular®), Cox 2 inhibitors, such as Celebrex®, steroids; chemotherapeutic agents (anti-ne
- Fluorides such as stannous fluoride and sodium fluoride, are effective in reducing the incidence of dental carries. Although fluorinated water has been widely advocated to reduce the incidence of dental carries, only about 65% of the United States population receive fluorinated water.
- the extent of caries control is generally directly related to the number of times the fluoride is applied and the length of time the fluoride is in contact with the teeth. It is better to apply lower concentrations of fluoride to the teeth more often than to apply higher concentrations at longer intervals.
- Fluorinated dental floss is a convenient and effective delivery system for frequent applications of low levels of fluoride.
- Z. Us, C. ⁇ ren, T. Ulusu, and T. Orbey, J. Dent. Child., 62(4), 274-278 (1995) concluded that use of fluoride containing dental floss is an effective method for increasing the fluoride content of interproximal surfaces, which are difficult to access and vulnerable to dental carries.
- Chlorhexidine a cationic biguanide microbiocide with a broad spectrum of activity against many forms of bacteria and fungi, is a common antibacterial agent widely used in both clinical and domestic applications. It is effective in reducing the activity of many common strains of oral flora. Chlorhexidine rinse is currently considered to be the most effective rinse to control plaque bacteria. Chlorhexidine has been a popular agent in many studies of gingivitis reversal and prevention and is used to overcome the ill effects of chronic gingivitis. However, when chlorhexidine is applied as an oral rinse, the contact time between the chlorhexidine and the oral cavity is very brief and much of the microbiocide agent is not retained. Bis-biguanides are described, for example, in Gundersen, U.S. Pat. No. 4,022,834, and Eustis, III, U.S. Pat. No. 4,053,636, incorporated herein by reference.
- nylon nylon
- nylon 612 nylon 12, nylon 6,12, etc.
- Any polyamide polymer such as nylon 6,6, nylon 6, nylon 12, nylon 6,12, etc., in the form a resin, fiber, yarn, gauze, etc., can be used as a delivery system for penicillin.
- the fiber may also comprise abrasive matter included within the fiber, on the surface of the fiber, or a combination thereof.
- the abrasive matter may be incorporated into any part of the body of the fiber, such as for example the primary or secondary filaments or both. It may also be incorporated on the surface of any or all the primary or secondary filaments, by any well known to the art techniques. When the abrasive matter is incorporated in the body of the filaments, and especially filaments of the core, care should be taken not to overfill the filament with abrasive matter to the point that it loses its strength and elasticity.
- Any conventional polishing matter used for example for polishing teeth, or mixture thereof, may be employed as an abrasive matter for the purposes of the present invention.
- This includes, but is not limited to appropriate oxides, such as aluminum oxide and silicon dioxide, silicates, carbonates, such as calcium carbonate, phosphates, and the like.
- Preferable materials are pumice, talc, calcium silicate, calcium carbonate, and zirconium oxide.
- the average particle size is preferably lower than 50 micrometers, and more preferably in the range of 1 to 15 micrometers.
- the fiber may also include a wetting agents, such as detergents and surfactants; flavor oils, such as peppermint oil; pigments and/or coloring materials, such as titanium dioxide; antioxidants; etc.
- a wetting agents such as detergents and surfactants
- flavor oils such as peppermint oil
- pigments and/or coloring materials such as titanium dioxide; antioxidants; etc.
- the imbibed dental floss of this invention comprises much higher levels of chemotherapeutic agent than could be previously obtained. This high uptake is a consequence of the filament and the substance used. These high levels are by imbibing the substance or substances into the fiber instead of coating them on the surface of the fiber.
- the dental floss comprises at least about 500 ppm fluoride, preferably at least about 1,000 ppm fluoride, more preferably at least about 1,500 ppm fluoride, and most preferably at least about 2,000 ppm fluoride.
- the imbibed fluoride is water soluble, so it is extracted from the imbibed dental floss during use. As discussed below in Comparative Example 1, treatment of conventional dental floss with fluoride containing solutions produces dental floss that comprises less than 500 ppm fluoride.
- the chemotherapeutic agent or agents may be conveniently imbibed into the fiber to form the imbibed dental floss by dissolving the substance or substances in a hot solvent, adding the fiber to the hot solution, and allowing the solution to cool.
- Strongly acidic solutions such as 0.1 M phosphoric acid (pH about 1), and long treatment times, e.g., twenty four hours or longer, are not required to achieve high levels of uptake of substances such as fluoride.
- Solutions or dispersions with a pH greater than about 2, preferably greater than about 3, and treatment times less than twenty four hours, preferably about 12 hours of less, may be used.
- Hot water will typically be the solvent of choice, because water is non-toxic and non-flammable.
- the substance will typically be soluble or dispersible in water.
- the substance may be imbibed into the fiber by allowing the fiber to stand in a dilute aqueous solution of the substance, allowing diffusion to occur.
- the imbibed polymer may be in the form of a shaped article, such as a dental tape; a monolith; or a fiber.
- Imbibed fiber may be in the form of a dental floss, a gauze pad, or any other from useful for the delivery of chemotherapeutic agent, especially substances useful in dental hygiene.
- imbibed dental floss When imbibed dental floss is used as a delivery system for substances useful in dental hygiene, the user of the dental floss stretches the fiber to the desired degree and forces it through two adjacent teeth. In sequence, the user reciprocates the floss of this invention back and forth. During this process the floss becomes wet, and the substance or substances useful in dental hygiene imbibed in the fiber are extracted from the floss. Stretching of the fiber promotes egress of the substance or substances, enhancing their delivery. This process is continued for a time sufficient to extract most or all of the substance or substances from the imbibed dental floss. This time will depend on the nature and amount of substance or substances present in the imbibed dental floss.
- the imbibed dental floss may be in the form of a continuous strand, or a strand cut into adequately long pieces for flossing the teeth of a person.
- the imbibed dental floss or strand may be assembled in a dispensing box so that the fiber is at least partially enclosed in the box for purposes of cleanliness and convenience.
- the dispensing box typically has a means for the user to cut a continuous strand to the desired length. Such boxes are well known in the art.
- the imbibed dental floss may also be assembled in combination with a dental instrument, so that the fiber is supported by the dental instrument in a manner to facilitate flossing of a person's teeth.
- the dental instrument is preferably disposable and made of plastic material.
- Other types of dental instruments are exemplified in U.S. Pat. Nos. 3,236,247, 5,010,906, 5,267,579, and 5,280,797, which are incorporated herein by reference.
- Imbibed fiber in the form of a gauze pad or a specially shaped article containing imbibed polymer may be placed in the mouth and applied to the area in need of therapy, such as for example, the teeth, gums, mucosal membranes, or the mouth in general.
- This example illustrates preparation of a fluoride imbibed dental floss of the invention.
- Lycra® spandex (12.3 g, 540 denier) was treated as follows. A solution of 14.0 g of sodium fluoride in 200 mL of deionized water was heated to 95° C. This solution was poured onto the spandex. The spandex was soaked in the solution for 30 min as the solution cooled to room temperature. The fluoride solution was decanted from the spandex, and the spandex was washed with three 200 mL portions of deionized water and dried for 4 hr under vacuum. This sample of sodium fluoride imbibed dental floss analyzed for 0.23% (2300 ppm) fluoride, indicating a very high uptake of sodium fluoride.
- Conventional dental floss (12.0 g, TreasuryTM Brand Un-Waxed, Un-Flavored) was treated as follows. A solution of 14.0 g of sodium fluoride in 200 mL of deionized water was heated to 95° C. This solution was poured onto the floss. The floss was soaked in the solution for 30 min as the solution cooled to room temperature. The fluoride solution was decanted from the floss, and the floss was washed with three 200 mL portions of deionized water and dried for 4 hr under vacuum. This sample of sodium fluoride imbibed dental floss analyzed for 385 ppm of fluorine, indicating a very poor uptake of sodium fluoride.
- Impregnating ⁇ ⁇ Agent ppm ⁇ ⁇ fluoride NaF ⁇ ⁇ mouthwash ⁇ ⁇ ( 225 ⁇ ⁇ ppm ⁇ ⁇ F ) 201 ⁇ 19 ⁇ ⁇ ppm ⁇ F ⁇ ⁇ dentrifice ⁇ ⁇ slurry ⁇ ⁇ ( 275 ⁇ ⁇ ppm ⁇ ⁇ F ) 248 ⁇ 17 ⁇ ⁇ ppm _
- This example illustrates the dental floss of the invention as a delivery system for fluoride.
- Example 1 Sodium fluoride imbibed spandex dental floss (2.71 g) formed in Example 1 was soaked in 12.0 g of deionized water at room temperature for 1 min. The water analyzed for 220 ppm of fluorine as sodium fluoride.
- Example 1 Sodium fluoride imbibed spandex dental floss (2.55 g) formed in Example 1 was soaked in 12.0 g of deionized water at room temperature for 2 min. The water analyzed for 330 ppm of fluorine as sodium fluoride.
- Example 1 Sodium fluoride imbibed spandex dental floss (2.58 g) formed in Example 1 was soaked in 12.0 g of deionized water at room temperature for 60 min. The water analyzed for 309 ppm of fluorine as sodium fluoride.
- This example illustrates extraction of sodium fluoride from conventional dental floss treated with sodium fluoride.
- This example illustrates preparation of penicillin containing dental floss.
- Penicillin G potassium solution was prepared with a concentration of 15,000 units/cc by diluting 5 million units of penicillin as a powder in 20 cc of sterile water and diluting 15 cc of this solution to 250 cc. This was done under clean, but not sterile, conditions.
- Filaments tested were: spandex (Lycra® spandex denier 2240), spandex with the coating of silicone oil coating removed, non-waxed nylon dental floss, and Hytrel® elastomer.
- the silicone oil coating was removed by placing the Lycra® spandex in water at 100° C. for 5 minutes, as described by the manufacturer.
- each sample was washed in distilled water by swishing the fiber back and forth three times before allowing the filaments to dry in room air. The samples were stored for eight days prior to testing.
- the degree of antibiotic activity was determined by the size of the area around the fiber than showed no growth of bacteria. Results were graded from negative ( ⁇ ), meaning no impairment of bacterial growth, to 3+, meaning marked impairment of bacterial growth. The results are shown in the following table were determined by a visual comparison of two observers. Sample 30 min@25° C. 30 min@100° C. 6 hr@25° C. Control spandex 2+ 3+ 2+ — spandex 1+ 2+ 2+ — (less oil finish) nylon no-wax 3+ 3+ 2+ — floss Hytrel ® 1+ 1+ — — filament
- the untreated control had no observable effect on bacterial growth. All the imbibed dental flosses markedly arrested bacterial growth in a pattern radiating from the filament, indicating outward diffusion of penicillin. The size of the area of arrested bacterial growth was, within observable limits, a function of imbibing time.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
An imbibed fiber that can be used as a delivery system for chemotherapeutic agents, especially substances useful in dental hygiene, is disclosed. The imbibed fiber comprises a fiber of an elastomeric polymer capable of imbibing the chemotherapeutic agents. A preferred elastomeric fiber is spandex. The fiber may be in the form of a dental floss, dental tape, gauze pad, or the like. A therapeutically effective amount of the agent is imbibed in the elastomeric polymer.
Description
- This application claims priority from U.S. Provisional Application 60/073,755, filed Feb. 5, 1998, incorporated herein by reference.
- This invention relates to dental hygiene. In particular, this invention relates an imbibed fiber that can be used as a delivery system for substances useful in dental hygiene.
- Dental floss is a very well known and broadly used article of dental hygiene. There are many benefits attributed to dental flossing, and especially daily dental flossing. Dental flossing removes residual food particles, which cannot be removed by brushing, from in between teeth, and in general maintains the gums in good health. Thus, among other benefits, it decreases the incidence of dental caries, gingivitis, halitosis, and dysgeusia (bad taste). It may also reduce the incidence of plaque formation.
- Providing therapeutic quantities of substances useful in dental hygiene to the interdental spaces is a desirable use of dental floss. Conventional dental floss materials, such as nylon, cotton, perfluorinated polyolefins (Teflon®, Gore-Tex®), are “hard” and, therefore, relatively impermeable. Conventional dental floss materials are, for this purpose, limited to using coatings containing the dental hygiene substance, limiting efficacy. Ashton, U.S. Pat. No. 2,667,443, for example, discloses dental floss and dental tape containing chemicals for the purpose of increasing the resistance of teeth to dental caries. King, U.S. Pat. No. 2,772,205, discloses dental floss that has absorbed thereon a higher aliphatic acyl amide of an amino carboxylic acid. Rosenberger, U.S. Pat. No. 5,280,796, discloses a dental floss coated with a microcrystalline wax containing a prophylactic, antimicrobial, analgesic and/or antiseptic material. Bowen, U.S. Pat. No. 5,603,921, discloses a method for preparing medicated dental floss in which polyethylene glycol containing an antimicrobial agent is coated onto the dental floss.
- The primary impediment to patient acceptance of flossing as part of routine oral hygiene procedures is the difficulty of passing floss through tight proximal contacts. Damage to the inter proximal papilla and/or tearing or shredding of the floss are the usual reasons cited by patients for failing to use this technique.
- Therefore, a need exists for a dental floss that imbibes substances useful in dental hygiene, delivers the substances in therapeutic doses to the interdental spaces where the user needs them, but is acceptable and comfortable to the user.
- The invention is a imbibed polymer, preferably an imbibed fiber, comprising:
- (a) a fiber of an elastomeric polymer capable of imbibing a chemotherapeutic agent; and
- (b) a therapeutically effective amount of the chemotherapeutic agent imbibed in the fiber.
- Although this invention is described with respect to use of the imbibed fiber in imbibed dental floss, the invention is not limited thereby. Imbibed polymer may be in the form of, for example, a dental tape, a molded object, or a monolith. The imbibed fiber may be in the form of, for example, yarn, fabric, or a gauze pad.
- The imbibed dental floss strand preferably comprises an elastomer having:
- 1) A tensile strength higher than 0.5 grams per denier, preferably more than 0.65 grams per denier, and more preferably more than 0.75 grams per denier.
- 2) The fiber requires a stress of either about 0.03 to 0.40 grams per denier, more preferably about 0.04 to 0.25 grams per denier, and even more preferably about 0.04 to 0.20 grams per denier, in order to develop an elongation of 200%, or about 0.07 to 0.60 grams per denier, more preferably about 0.08 to 0.50 grams per denier, and even more preferably about 0.09 to 0.30 grams per denier, in order to develop an elongation of 300%.
- 3) A break elongation of at least 200%, and more preferably of at least 300%; that is the fiber does not break before it elongates by at least that percent.
- The preferred denier value for the elastomeric fiber is about 40 to 4,000, preferably about 200 to 2,500, and more preferably about 800 to 2,400.
- Elastomeric fibers other than spandex fibers may be used as long as they fulfil these three important requirements along with the requirements of denier value, texture, smoothness, and the like. In addition, the fiber should preferably be stable with age. Preferably, the fiber should not lose more than 20% of its original tensile strength in one year, and more preferably it should lose not more than 10% per year.
- Elastomeric dental floss is disclosed in Burch, U.S. Pat. No. 5,433,266 (equivalent to WO 95/24167), incorporated herein by reference. The dental floss comprises a fiber having a core of a segmented polymer having soft segments and hard segments. The hard segments are selected from a group consisting of urethane, amide, imide, and mixtures thereof. Urethane hard segments are, however, highly preferable. In the fiber core, the hard and soft segments belong to the same polymer and they are linked chemically by covalent bonds. The hard segments give the fibers and filaments strength and integrity. The soft segments give the fibers and filaments their elasticity.
- The core of the fiber has preferably a content of hard segment of 5-40% by weight, while the soft segments are preferably selected from the group consisting of polyester, polyether, and mixtures thereof. The structure of the core of the fiber is preferably selected from the group consisting of primary monofilament, primary multifilament, primary coalesced monofilament, and combinations thereof. The core of the fiber may be uncovered or bare core, core covered with a secondary filament, or a combination thereof. The secondary filament may be a secondary monofilament, secondary multifilament, spun filament, or a combination thereof.
- The content in hard segments is preferably in the range of 5-40% by weight of the total polymer, and more preferably in the range of 15-25% by weight of the total polymer. The content of the soft segment is preferably in the range of 60-95% by weight of the total polymer, and more preferably in the range of 75-85% by weight of the total polymer. Examples of such polymers are polymers having the generic name “spandex”. A review of spandex elastomeric fibers is given by L. Rose in the Reprints, Progress in Applied Chemistry (London), Vol. 51, p. 609, 1966, incorporated herein by reference. Meredith and Fyfe in Text. Inst. Ind., Vol. 2, p. 154, 1964, and Bamford in Text. Inst. Ind., Vol. 55, p. 73, 1965, discuss the structural aspects of spandex, and give suggestions about its elastomeric properties.
- The hard segments of preferably aromatic polyurea are linked occasionally to the soft segments through urethane bonds, and these bonds are analogous to the covalent sulfide bonds of vulcanized rubber. The soft segments consist of a polymeric structure with a glass transition temperature well below room temperature. The soft segments in the case of spandex, which are preferably polyethers, polyesters, or a combination thereof, have preferably low internal cohesion, and they are analogous to the hydrocarbon chains in the case of natural rubber. The soft segments can dissolve other substances, such as those useful in dental hygiene.
- U.S. Pat. Nos. 2,692,873, 2,751,363, 2,751,419, 3,061,574, 3,071,557, 3,133,036, and 3,149,998, British Patents 934,519 and 1,040,055, as well as Canadian Patent 692,058, all of which are incorporated herein by reference, give examples of making spandex compositions and fibers. Examples of commercial products suitable for the practice of this invention are the Lycra® spandex fibers (DuPont, Wilmington, Del.). The structure and properties of Lycra® spandex fibers are briefly discussed by Hicks in the American Dyestuff Reporter, pp. 33-35, Jan. 7, 1963. Hytrel® elastomer (DuPont, Wilmington, Del.) may also be useful, but its low content of soft segments limits the amount of substance that may be imbibed in the fiber. Natural rubber may also be useful, but its hydrocarbon-like character limits the type of substances to that can be imbibed to hydrocarbon-like small molecules and its low tensile strength is a problem in dental applications.
- Unlike conventional dental floss, which has a constant diameter and may be too small for some regions between adjacent teeth and too large for other, spandex fiber has a variable diameter that depends on stretching. The diameter decreases with stretch and percent decrease in diameter related to the degree of stretch. It returns to original diameter with release of stretch. Thus, it can accommodate and clean spacings of different dimensions between teeth. Other important advantages of spandex fibers include, but are not limited to: easy and safe to use, i.e., the variable diameter with stretch enables use in variable teeth spacing; because of its good tensile strength, it does not break easily, as compared to rubber dental floss, which is prone to break easily and injure the gums of the user; once wrapped around the index finger for use, the stretch release anchors the spandex fiber with less chance of slipping, when compared to regular floss; and considerably more comfortable to the gums. Its wet smooth surface avoids gum injury. It is hypo-allergenic, and it does not have the tackiness, stickiness and unpleasant odor of rubber. It is inexpensive. It is believed to be in general more conducive to widespread flossing as compared to flossing with either non-elastic or rubber made dental floss. In contrast to rubber, it does not become brittle with time, so it may be stored for indefinite periods of time without premature breaking due to aging, which can cause gum injury during flossing. It is readily available in a variety of deniers to accommodate various interdental spacings. It is adequately elastic to reversibly stretch when subjected to a stress, but the stress required for further stretching increases considerably with elongations in the range of 200 to 400%. This, combined with the rather high tensile strength as compared to other elastomers, gives spandex fiber the robust behavior needed for its use in imbibed dental floss.
- The core of the fiber may be a primary monofilament. The primary monofilament preferably has a round cross-section. However, the cross-section may have any other shape, such as for example square, rectangular, polygonal, irregular, and the like. The diameter of the primary monofilament may also be variable.
- The core of the fiber may also be in the form of a primary multifilament. Monofilaments may be woven together, twisted, and in general formed in any conventional manner that fibers are manufactured. Further, the monofilaments may be coalesced into one primary coalesced monofilament, somewhat similar to the primary multifilament, with the difference that the monofilaments have been fused together to a desired degree, at least at the contact regions of the monofilaments, to form the unitary primary coalesced monofilament.
- The core may be bare or covered partially or totally with a secondary monofilament or polyfilament. It may also be covered by more than one secondary mono- or multifilament. The core may be covered by a secondary spun filament. The secondary filaments may be any conventional fibers, elastomeric or non-elastic, such as, for example, nylon, acrylic, acetate, cotton, wool, polyester, Lycra® spandex, other natural or synthetic fibers, and the like.
- The fiber comprises at least a therapeutically effective amount of a chemotherapeutic agent, especially a substance useful in dental hygiene. The agent preferably has sufficient solubility in water so that it can be imbibed into the fiber and extracted from the fiber when the fiber is placed in the user's mouth. More than one agent may be included, if desired.
- By “therapeutically effective amount” is meant the amount necessary to achieve a desired therapeutic effect. As is well known to those skilled in the art this will depend on the agent used and the therapeutic effect desired.
- Chemotherapeutic agents, especially substances useful in dental hygiene, can be imbibed into the fiber. Chemotherapeutic agents include, but are not limited to, chemical agents used as bacteriacidals, antiseptics, anti-inflammatories, anti-fungals, and agents for the treatment of cancer. These include, but are not limited to: anti-bacterials, such as sulfonamides, penicillins, trimethoprim, and, zinc salts, such as zinc acetate and zinc chloride; anti-amoebics; anti-yeasts; anti-fungals, such as nystatin and fluconazole; antiseptics, for example, fluorides, such as sodium fluoride and stannous fluoride, chlorhexidine, triclosan, thymol, chloroxylenol, hexachlorophene, phenol derivatives, such as sodium phenolate and 4-hexylresorcinol; anti-inflammatory agents, for example, salicylates, such as aspirin, phenylacetic acids, such as ibuprofen, indoleacetic acids, such as indocin, ketorolac tromethamine (Acular®), Cox 2 inhibitors, such as Celebrex®, steroids; chemotherapeutic agents (anti-neoplastic agents), such as 5-fluorouracil (5-FU), methotrexate, and cyclophosphamide; surface active agents, such as the polyethyleneimines in which 5 to 95 mole % of the nitrogen atoms have been derivatized by reaction with C 8-20 fatty acid halides and 5 to 95 mole % of the nitrogen atoms have been quaternized with HF disclosed in Homola, U.S. Pat. No. 5,665,333, incorporated herein by reference. Other materials that may be imbibed into the fiber include, for example, flavors; nascent oxygen generating agents, such as calcium peroxide; desensitizing agents, such as sodium nitrite and the barbiturates disclosed in Breuer, U.S. Pat. No. 5,252,577, incorporated herein by reference; etc. Other chemotherapeutic agents, especially those useful in dental hygiene, will be apparent to those skilled in the art.
- Fluorides, such as stannous fluoride and sodium fluoride, are effective in reducing the incidence of dental carries. Although fluorinated water has been widely advocated to reduce the incidence of dental carries, only about 65% of the United States population receive fluorinated water.
- The extent of caries control is generally directly related to the number of times the fluoride is applied and the length of time the fluoride is in contact with the teeth. It is better to apply lower concentrations of fluoride to the teeth more often than to apply higher concentrations at longer intervals. Fluorinated dental floss is a convenient and effective delivery system for frequent applications of low levels of fluoride. Z. Us, C. Ören, T. Ulusu, and T. Orbey, J. Dent. Child., 62(4), 274-278 (1995), concluded that use of fluoride containing dental floss is an effective method for increasing the fluoride content of interproximal surfaces, which are difficult to access and vulnerable to dental carries.
- Chlorhexidine, a cationic biguanide microbiocide with a broad spectrum of activity against many forms of bacteria and fungi, is a common antibacterial agent widely used in both clinical and domestic applications. It is effective in reducing the activity of many common strains of oral flora. Chlorhexidine rinse is currently considered to be the most effective rinse to control plaque bacteria. Chlorhexidine has been a popular agent in many studies of gingivitis reversal and prevention and is used to overcome the ill effects of chronic gingivitis. However, when chlorhexidine is applied as an oral rinse, the contact time between the chlorhexidine and the oral cavity is very brief and much of the microbiocide agent is not retained. Bis-biguanides are described, for example, in Gundersen, U.S. Pat. No. 4,022,834, and Eustis, III, U.S. Pat. No. 4,053,636, incorporated herein by reference.
- Surprisingly, it was found that although polyamide (nylon) fiber weakly imbibes sodium fluoride, it strongly imbibes penicillin. Although this invention is not bound by any particular theory or explanation, it is believed that the active amine ends in the nylon take up penicillins that are active toward amine chemical functionality. Any polyamide polymer, such as nylon 6,6, nylon 6, nylon 12, nylon 6,12, etc., in the form a resin, fiber, yarn, gauze, etc., can be used as a delivery system for penicillin.
- The fiber may also comprise abrasive matter included within the fiber, on the surface of the fiber, or a combination thereof. The abrasive matter may be incorporated into any part of the body of the fiber, such as for example the primary or secondary filaments or both. It may also be incorporated on the surface of any or all the primary or secondary filaments, by any well known to the art techniques. When the abrasive matter is incorporated in the body of the filaments, and especially filaments of the core, care should be taken not to overfill the filament with abrasive matter to the point that it loses its strength and elasticity.
- Any conventional polishing matter, used for example for polishing teeth, or mixture thereof, may be employed as an abrasive matter for the purposes of the present invention. This includes, but is not limited to appropriate oxides, such as aluminum oxide and silicon dioxide, silicates, carbonates, such as calcium carbonate, phosphates, and the like. Preferable materials are pumice, talc, calcium silicate, calcium carbonate, and zirconium oxide. The average particle size is preferably lower than 50 micrometers, and more preferably in the range of 1 to 15 micrometers.
- The fiber may also include a wetting agents, such as detergents and surfactants; flavor oils, such as peppermint oil; pigments and/or coloring materials, such as titanium dioxide; antioxidants; etc.
- The imbibed dental floss of this invention comprises much higher levels of chemotherapeutic agent than could be previously obtained. This high uptake is a consequence of the filament and the substance used. These high levels are by imbibing the substance or substances into the fiber instead of coating them on the surface of the fiber. For example, the dental floss comprises at least about 500 ppm fluoride, preferably at least about 1,000 ppm fluoride, more preferably at least about 1,500 ppm fluoride, and most preferably at least about 2,000 ppm fluoride. The imbibed fluoride is water soluble, so it is extracted from the imbibed dental floss during use. As discussed below in Comparative Example 1, treatment of conventional dental floss with fluoride containing solutions produces dental floss that comprises less than 500 ppm fluoride.
- The chemotherapeutic agent or agents may be conveniently imbibed into the fiber to form the imbibed dental floss by dissolving the substance or substances in a hot solvent, adding the fiber to the hot solution, and allowing the solution to cool. Strongly acidic solutions, such as 0.1 M phosphoric acid (pH about 1), and long treatment times, e.g., twenty four hours or longer, are not required to achieve high levels of uptake of substances such as fluoride. Solutions or dispersions with a pH greater than about 2, preferably greater than about 3, and treatment times less than twenty four hours, preferably about 12 hours of less, may be used.
- Other solvents, such as lower alcohols and mixtures of lower alcohols and water may be used. Hot water will typically be the solvent of choice, because water is non-toxic and non-flammable. The substance will typically be soluble or dispersible in water. Alternatively, if the substance is not stable to heat, the substance may be imbibed into the fiber by allowing the fiber to stand in a dilute aqueous solution of the substance, allowing diffusion to occur.
- The imbibed polymer may be in the form of a shaped article, such as a dental tape; a monolith; or a fiber. Imbibed fiber may be in the form of a dental floss, a gauze pad, or any other from useful for the delivery of chemotherapeutic agent, especially substances useful in dental hygiene.
- When imbibed dental floss is used as a delivery system for substances useful in dental hygiene, the user of the dental floss stretches the fiber to the desired degree and forces it through two adjacent teeth. In sequence, the user reciprocates the floss of this invention back and forth. During this process the floss becomes wet, and the substance or substances useful in dental hygiene imbibed in the fiber are extracted from the floss. Stretching of the fiber promotes egress of the substance or substances, enhancing their delivery. This process is continued for a time sufficient to extract most or all of the substance or substances from the imbibed dental floss. This time will depend on the nature and amount of substance or substances present in the imbibed dental floss.
- The imbibed dental floss may be in the form of a continuous strand, or a strand cut into adequately long pieces for flossing the teeth of a person. The imbibed dental floss or strand may be assembled in a dispensing box so that the fiber is at least partially enclosed in the box for purposes of cleanliness and convenience. The dispensing box typically has a means for the user to cut a continuous strand to the desired length. Such boxes are well known in the art.
- The imbibed dental floss may also be assembled in combination with a dental instrument, so that the fiber is supported by the dental instrument in a manner to facilitate flossing of a person's teeth. The dental instrument is preferably disposable and made of plastic material. Other types of dental instruments are exemplified in U.S. Pat. Nos. 3,236,247, 5,010,906, 5,267,579, and 5,280,797, which are incorporated herein by reference.
- Imbibed fiber in the form of a gauze pad or a specially shaped article containing imbibed polymer may be placed in the mouth and applied to the area in need of therapy, such as for example, the teeth, gums, mucosal membranes, or the mouth in general.
- The advantageous properties of this invention can be observed by reference to the following examples which illustrate, but do not limit, the invention.
- This example illustrates preparation of a fluoride imbibed dental floss of the invention.
- Lycra® spandex (12.3 g, 540 denier) was treated as follows. A solution of 14.0 g of sodium fluoride in 200 mL of deionized water was heated to 95° C. This solution was poured onto the spandex. The spandex was soaked in the solution for 30 min as the solution cooled to room temperature. The fluoride solution was decanted from the spandex, and the spandex was washed with three 200 mL portions of deionized water and dried for 4 hr under vacuum. This sample of sodium fluoride imbibed dental floss analyzed for 0.23% (2300 ppm) fluoride, indicating a very high uptake of sodium fluoride.
- This example illustrates preparation of sodium fluoride treated conventional dental floss.
- Conventional dental floss (12.0 g, Treasury™ Brand Un-Waxed, Un-Flavored) was treated as follows. A solution of 14.0 g of sodium fluoride in 200 mL of deionized water was heated to 95° C. This solution was poured onto the floss. The floss was soaked in the solution for 30 min as the solution cooled to room temperature. The fluoride solution was decanted from the floss, and the floss was washed with three 200 mL portions of deionized water and dried for 4 hr under vacuum. This sample of sodium fluoride imbibed dental floss analyzed for 385 ppm of fluorine, indicating a very poor uptake of sodium fluoride.
- J. Jøgensen, M. Shariati, C. P. Shields, D. P. Durr, and H. M. Proskin, Pediatric Dentistry, 11(1), 17-20 (1989) measured the uptake of fluoride by soft filament dental floss (Super-Floss®—Oral-B Laboratories) from a fluoride containing mouthwash and a fluoride containing toothpaste. The reported results, summarized below, are similar to those reported above.
- This example illustrates the dental floss of the invention as a delivery system for fluoride.
- Sodium fluoride imbibed spandex dental floss (2.71 g) formed in Example 1 was soaked in 12.0 g of deionized water at room temperature for 1 min. The water analyzed for 220 ppm of fluorine as sodium fluoride.
- Sodium fluoride imbibed spandex dental floss (2.55 g) formed in Example 1 was soaked in 12.0 g of deionized water at room temperature for 2 min. The water analyzed for 330 ppm of fluorine as sodium fluoride.
- Sodium fluoride imbibed spandex dental floss (2.58 g) formed in Example 1 was soaked in 12.0 g of deionized water at room temperature for 60 min. The water analyzed for 309 ppm of fluorine as sodium fluoride.
- For reference, the deionized water analyzed for 3 ppm of fluorine as sodium fluoride, and the fluoride-treated local municipal water supply analyzed for 4 ppm of fluorine as sodium fluoride.
- These results show that spandex dental floss imbibed with sodium fluoride is an effective delivery system for sodium fluoride.
- This example illustrates extraction of sodium fluoride from conventional dental floss treated with sodium fluoride.
- Sodium fluoride treated dental floss (2.52 g) formed in Comparative Example 1 was soaked in 13.2 g of deionized water at room temperature for 1 min. The water analyzed for 58 ppm of fluorine as sodium fluoride.
- Sodium fluoride treated dental floss (2.52 g) formed in Comparative Example 1 was soaked in 13.2 g of deionized water at room temperature for 2 min. The water analyzed for 37 ppm of fluorine as sodium fluoride.
- These results show that conventional dental floss is ineffective for delivering therapeutic doses of sodium fluoride.
- This example illustrates preparation of penicillin containing dental floss.
- Penicillin G potassium solution was prepared with a concentration of 15,000 units/cc by diluting 5 million units of penicillin as a powder in 20 cc of sterile water and diluting 15 cc of this solution to 250 cc. This was done under clean, but not sterile, conditions.
- Filaments tested were: spandex (Lycra® spandex denier 2240), spandex with the coating of silicone oil coating removed, non-waxed nylon dental floss, and Hytrel® elastomer. The silicone oil coating was removed by placing the Lycra® spandex in water at 100° C. for 5 minutes, as described by the manufacturer.
- Three inch segments of each of the filaments were treated under each of the following conditions:
- 1. Soaked in the penicillin solution at room temperature for 30 minutes.
- 2. Soaked in the penicillin solution at 100° C. for 30 minutes.
- 3. Soaked in the penicillin solution at room temperature for 6 hours.
- 4. Control—no treatment at all.
- After treatment, each sample was washed in distilled water by swishing the fiber back and forth three times before allowing the filaments to dry in room air. The samples were stored for eight days prior to testing.
- Plain Meuller Hinton agar plates were plated with penicillin sensitive Staph Aureus strain ATCC 25923 bacteria. A strand of each of the fibers was placed in each plate and the plates incubated for 24 hr and then read.
- The degree of antibiotic activity was determined by the size of the area around the fiber than showed no growth of bacteria. Results were graded from negative (−), meaning no impairment of bacterial growth, to 3+, meaning marked impairment of bacterial growth. The results are shown in the following table were determined by a visual comparison of two observers.
Sample 30 min@25° C. 30 min@100° C. 6 hr@25° C. Control spandex 2+ 3+ 2+ — spandex 1+ 2+ 2+ — (less oil finish) nylon no-wax 3+ 3+ 2+ — floss Hytrel ® 1+ 1+ — — filament - The untreated control had no observable effect on bacterial growth. All the imbibed dental flosses markedly arrested bacterial growth in a pattern radiating from the filament, indicating outward diffusion of penicillin. The size of the area of arrested bacterial growth was, within observable limits, a function of imbibing time.
- Having described the invention, we now claim the following and their equivalents.
Claims (24)
1. An imbibed fiber comprising:
(a) a fiber of an elastomeric polymer capable of imbibing a chemotherapeutic agent; and
(b) a therapeutically effective amount of the chemotherapeutic agent imbibed in the fiber.
2. The imbibed fiber of claim 1 in which the fiber has a core of a segmented polymer; the segmented polymer has soft segments and hard segments; the hard segments are selected from the group consisting of urethane, amide, imide, and mixtures thereof; the soft segments are selected from the group consisting of polyester, polyether, and mixtures thereof; and the hard segments are linked to the soft segments by covalent bonds.
3. The imbibed fiber of claim 2 in which the chemotherapeutic agent is a substance useful in dental hygiene.
4. The imbibed fiber of claim 1 in which the fiber has:
a denier value in the range of 40 to 4,000;
a tensile strength higher than 0.5 grams per denier; and
a break elongation of at least 400%;
the fiber requiring a stress to elongate selected from the group consisting of 0.03 to 0.4 grams per denier to develop an elongation of 200% and 0.07 to 0.6 grams per denier to develop an elongation of 300%.
5. The imbibed fiber of claim 5 in which the fiber has a core of a segmented polymer; the segmented polymer has soft segments and hard segments; the hard segments are selected from the group consisting of urethane, amide, imide, and mixtures thereof; and the hard segments are linked to the soft segments by covalent bonds.
6. The imbibed fiber of claim 5 in which the chemotherapeutic agent is a substance useful in dental hygiene.
7. The imbibed fiber of claim 5 in which the chemotherapeutic agent is selected from the group consisting of sodium fluoride and stannous fluoride.
8. The imbibed fiber of claim 5 in which the chemotherapeutic agent is a penicillin.
9. The imbibed fiber of claim 5 in which the chemotherapeutic agent is chlorhexidine.
10. An assembly comprising a box and an imbibed dental floss at least partially enclosed in said box, the imbibed dental floss comprising:
(a) a fiber of an elastomeric polymer capable of imbibing a chemotherapeutic agent; and
(b) a therapeutically effective amount of the chemotherapeutic agent imbibed in the fiber.
11. The assembly of claim 10 in which the fiber has a core of a segmented polymer; the segmented polymer has soft segments and hard segments; the hard segments are selected from the group consisting of urethane, amide, imide, and mixtures thereof; the soft segments are selected from the group consisting of polyester, polyether, and mixtures thereof; and the hard segments are linked to the soft segments by covalent bonds.
12. The assembly of claim 11 in which the fiber has:
a denier value in the range of 40 to 4,000;
a tensile strength higher than 0.5 grams per denier; and
a break elongation of at least 400%;
the fiber requiring a stress to elongate selected from the group consisting of 0.03 to 0.4 grams per denier to develop an elongation of 200% and 0.07 to 0.6 grams per denier to develop an elongation of 300%.
13. The assembly of claim 12 in which the fiber comprises at least about 2,000 ppm of water soluble fluoride.
14. A fluoride-containing fiber prepared by adding a fiber to an aqueous solution or dispersion of a fluoride salt for a time sufficient for the fiber to imbibe fluoride;
in which:
the pH of the aqueous solution or dispersion is greater than about 1; and
the fluoride-containing fiber comprises at least about 1,000 ppm of water soluble fluoride.
15. The fluoride-containing fiber of claim 14 in which the fiber comprises at least about 2,000 ppm of water soluble fluoride.
16. The fluoride-containing fiber of claim 14 in which the time sufficient for the fiber to imbibe fluoride is less than twenty four hours.
17. The fluoride-containing fiber of claim 15 in which the fiber has:
a denier value in the range of 40 to 4,000;
a tensile strength higher than 0.5 grams per denier; and
a break elongation of at least 400%;
the fiber requiring a stress to elongate selected from the group consisting of 0.03 to 0.4 grams per denier to develop an elongation of 200% and 0.07 to 0.6 grams per denier to develop an elongation of 300%.
18. The fluoride-containing fiber of claim 17 in which the fiber comprises at least about 2,000 ppm of water soluble fluoride.
19. A method for preparing a fluoride-containing fiber, the method comprising adding a fiber to an aqueous solution or dispersion of a fluoride salt for a time sufficient for the fiber to imbibe fluoride;
in which:
the pH of the aqueous solution or dispersion is greater than about 1; and
the fluoride-containing fiber comprises at least about 1,000 ppm of water soluble fluoride.
20. A method for preparing an imbibed fiber of an elastomeric polymer capable of imbibing a chemotherapeutic agent comprising a therapeutically effective amount of the chemotherapeutic agent, the method comprising adding a fiber to an aqueous solution or dispersion of a chemotherapeutic agent for a time sufficient for the fiber to imbibe the therapeutically effective amount of the chemotherapeutic agent;
in which:
the fiber has a denier value in the range of 40 to 4,000, a tensile strength higher than 0.5 grams per denier, and a break elongation of at least 400%;
the fiber requires a stress to elongate selected from the group consisting of 0.03 to 0.4 grams per denier to develop an elongation of 200% and 0.07 to 0.6 grams per denier to develop an elongation of 300%.
21. The method of claim 20 in which the aqueous solvent is water.
22. The method of claim 20 in which the fiber has a core of a segmented polymer; the segmented polymer has soft segments and hard segments; the hard segments are selected from the group consisting of urethane, amide, imide, and mixtures thereof; the soft segments are selected from the group consisting of polyester, polyether, and mixtures thereof; and the hard segments are linked to the soft segments by covalent bonds.
23. An imbibed polymer comprising:
(a) a polymer capable of imbibing penicillin; and
(b) a therapeutically effective amount penicillin imbibed in the polymer.
24. The imbibed polymer of claim 23 in which the polymer is nylon.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/245,625 US20020006415A1 (en) | 1998-02-05 | 1999-02-05 | Chemically active fiber compositions as delivery system for chemotherpeutic agents, epecially for substances useful in dental hygiene |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7375598P | 1998-02-05 | 1998-02-05 | |
| US09/245,625 US20020006415A1 (en) | 1998-02-05 | 1999-02-05 | Chemically active fiber compositions as delivery system for chemotherpeutic agents, epecially for substances useful in dental hygiene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20020006415A1 true US20020006415A1 (en) | 2002-01-17 |
Family
ID=26754845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/245,625 Abandoned US20020006415A1 (en) | 1998-02-05 | 1999-02-05 | Chemically active fiber compositions as delivery system for chemotherpeutic agents, epecially for substances useful in dental hygiene |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US20020006415A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060243298A1 (en) * | 2005-04-28 | 2006-11-02 | The Procter & Gamble Company | Dental floss compositions comprising menthol and carboxamides |
| WO2010057885A3 (en) * | 2008-11-18 | 2010-12-09 | Klaus-Uwe Busch | Combination of two material compositions for an oral hygiene product |
| US20150209192A1 (en) * | 2013-12-16 | 2015-07-30 | Empire Technology Development Llc | Endothermic sponge |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5098711A (en) * | 1988-11-14 | 1992-03-24 | Ira Hill | Method of treating the oral cavity with dental floss containing chemotherapeutic agents |
| US5433226A (en) * | 1994-03-09 | 1995-07-18 | Delta Dental Hygienics, L.L.C. | Dental floss based on robust segmented elastomer |
| US5499917A (en) * | 1993-06-29 | 1996-03-19 | Minnesota Mining And Manufacturing Company | Dental isolation dam |
| US5595750A (en) * | 1991-08-09 | 1997-01-21 | E. I. Du Pont De Nemours And Company | Antimicrobial particles of silver and barium sulfate or zinc oxide |
-
1999
- 1999-02-05 US US09/245,625 patent/US20020006415A1/en not_active Abandoned
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5098711A (en) * | 1988-11-14 | 1992-03-24 | Ira Hill | Method of treating the oral cavity with dental floss containing chemotherapeutic agents |
| US5595750A (en) * | 1991-08-09 | 1997-01-21 | E. I. Du Pont De Nemours And Company | Antimicrobial particles of silver and barium sulfate or zinc oxide |
| US5499917A (en) * | 1993-06-29 | 1996-03-19 | Minnesota Mining And Manufacturing Company | Dental isolation dam |
| US5433226A (en) * | 1994-03-09 | 1995-07-18 | Delta Dental Hygienics, L.L.C. | Dental floss based on robust segmented elastomer |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060243298A1 (en) * | 2005-04-28 | 2006-11-02 | The Procter & Gamble Company | Dental floss compositions comprising menthol and carboxamides |
| WO2010057885A3 (en) * | 2008-11-18 | 2010-12-09 | Klaus-Uwe Busch | Combination of two material compositions for an oral hygiene product |
| US20150209192A1 (en) * | 2013-12-16 | 2015-07-30 | Empire Technology Development Llc | Endothermic sponge |
| CN105828754A (en) * | 2013-12-16 | 2016-08-03 | 英派尔科技开发有限公司 | Endothermic sponge |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5433226A (en) | Dental floss based on robust segmented elastomer | |
| US5283924A (en) | Interdental foam brush and treatment gel combination therewith | |
| EP0759739B1 (en) | Improvements in dental floss | |
| ES2227565T3 (en) | PROCEDURES, COMPOSITIONS AND SYSTEMS OF DENTAL APPLICATION FOR THE PROTECTION OF THE SURFACE OF TEETH. | |
| US6340027B1 (en) | Extensible polishing mono-filament dental floss | |
| US5098711A (en) | Method of treating the oral cavity with dental floss containing chemotherapeutic agents | |
| US5165913A (en) | Controlled release interproximal delivery system | |
| RU2378023C2 (en) | Compositions and methods for prevention or reduction of dental deposit and/or gingivitis | |
| US5520924A (en) | Methods and articles for administering drug to the oral cavity | |
| ES2276430T3 (en) | METHODS, COMPOSITIONS AND SYSTEMS OF DENTAL ADMINISTRATION FOR THE PROTECTION OF THE SURFACES OF TEETH. | |
| US20250000775A1 (en) | Oral cavity cleaning composition method and apparatus | |
| US20060177384A1 (en) | Sialagogue coatings for interproximal devices | |
| US8863762B2 (en) | Elastomeric dental floss | |
| Prasanna et al. | Characteristics, uses and side effects of chlorhexidine-A review | |
| CN1482888A (en) | Hemostatic coated dental floss and dental tape | |
| PT676948E (en) | ANTIGENIC COMPOSITION ORAL ANTIGENGIVITE AND ANTICARIES | |
| US20140335474A1 (en) | Floss device, a method of forming the floss device and a method of using the floss device | |
| JP5926891B2 (en) | Oral care unit | |
| US20020006415A1 (en) | Chemically active fiber compositions as delivery system for chemotherpeutic agents, epecially for substances useful in dental hygiene | |
| US20050087208A1 (en) | PerioFloss for treatment of periodontitis | |
| Thurgood | Nurse maintenance of oral hygiene | |
| EP0506659B1 (en) | Dental floss with chemotherapeutic agents | |
| WO2005117740A2 (en) | Digital wipes and method of handling | |
| EP1107706A1 (en) | Extensible polishing mono-filament dental floss | |
| Farook et al. | A review of the effectiveness of antiseptic mouth rinses for oral health |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: DELTA DENTAL HYGIENICS LLC, LOUISIANA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:BURCH, ROBERT R.;BURCH, ROBERT R., JR.;REEL/FRAME:011591/0603;SIGNING DATES FROM 20010216 TO 20010221 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |